Please use this identifier to cite or link to this item:
https://doi.org/10.3390/ijerph16040605
| Title: | Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014 | Authors: | Bissell, Karen Ellwood, Philippa Ellwood, Eamon Chiang, Chen-Yuan Marks, Guy B El Sony, Asma Asher, Innes Billo, Nils Perrin, Christophe Asher, I Billo, NE Bissell, K Chiang, C-Y El Sony, A Ellwood, P Garcia-Marcos, L Mallol, J Marks, GB Pearce, N Strachan, D Priftanji, A Boukari, R Taright, S Gomez, M Baghdasaryan, A Burgess, S Marks, GB Mattes, J Tai, A Riedler, J Shpakou, A Weyler, J Lawin, H de Abruzzese, Aguirre J Domuz, S Brandao, H Camargos, PAM Fischer, GB Menezes, AM Porto Neto, AC Rosario, N Sole, D Mustakov, TB Birba, E Ngahane, Mbatchou BH Tse, SM Standring, P Aguirre, V Calvo Gil, MA Chen, Y-Z Kan, X Garcia, E Niederbacher, J Obel, Kabengele B Soto-Quiros, ME Banac, S Yiallouros, P Lochte, L Barba, S Bustos, C El Falaki, M Figueroa Colorado, M Weihe, P Lal, VA Makela, M Annesi-Maesano, I Raherison, C Annesi-Maesano, I Gotua, M von Mutius, E Addo-Yobo, EO Akpinar-Elci, M Lai, CKW Novak, Z Kabra, SK Ilangho, RP Pherwani, A Sharma, SK Sukumaran, TU Dalimunthe, W Karimi, M Masjedi, M-R Manning, P Shohat, T Forastiere, F La Grutta, S Petronio, MG Piffer, S Kahwa, E Odajima, H Abu-Ekteish, F Amukoye, EI Esamai, FO Hong, S-J Neziri-Ahmetaj, L Momen, JA Akkhavong, K Svabe, V Vlaski, E Mortimer, K Daud, M Montefort, S Del Rio Navarro, BE Jimenez Gonzalez, CA Merida-Palacio, J Paramo-Arroyo, RF Munkhbayarlakh, S Brunekreef, B Annesi-Maesano, I Asher, I Currie, S Douwes, J Graham, D Hancox, R Moyes, C Pattemore, P Vis, K Cordero, Rizo MZ Ayuk, A Falade, AG Garba, Ilah B Hammangabdo, A Onyia, N Pulu, M Nystad, W Al-Rawas, O Yusuf, MO Watson, BM El Sharif, N Cukier, G Chiarella, P Pagcatipunan, R Breborowicz, A Lis, G Morais-Almeida, M Annesi-Maesano, I Deleanu, D Kamaltynova, E Kondiurina, EG Esera-Tulifau, L Al-Ghamdi Memish, ZA Nahhas, MA Yousef, A Toure, NO Visnjevac, D Zivkovic, Z Deen, GF Goh, DYT Masekala, R Zar, HJ Carvajal-Uruena, I Garcia-Marcos, L Gonzalez Diaz, C Korta Murua, J Luna-Paredes, C Morales-Suarez-Varela, M Praena-Crespo, M Kudagammana, ST El Sony, A Mohammad, Y Guo, YL Huang, J-L Lao-Araya, M Teeratakulpisarn, J Vichyanond, P Anderson, S Tidjani, O Iosefa, T Aho, G Dookeeram, D Hamzaoui, A Yorgancioglu, A Ituaso-Conway, N Worodria, W Fedortsiv, O Mahboub, B Mansur, AH Kumar, H Valentin-Rostan, M Harrison, G Fiocchi, A Le, LTT Wa Somwe, S Manangazira, P |
Keywords: | Science & Technology Life Sciences & Biomedicine Environmental Sciences Public, Environmental & Occupational Health Environmental Sciences & Ecology essential medicines access noncommunicable diseases asthma inhaled corticosteroids bronchodilators national reimbursement list NONCOMMUNICABLE DISEASES LOW-INCOME ACCESS AVAILABILITY CHALLENGES |
Issue Date: | 2-Feb-2019 | Publisher: | MDPI | Citation: | Bissell, Karen, Ellwood, Philippa, Ellwood, Eamon, Chiang, Chen-Yuan, Marks, Guy B, El Sony, Asma, Asher, Innes, Billo, Nils, Perrin, Christophe, Asher, I, Billo, NE, Bissell, K, Chiang, C-Y, El Sony, A, Ellwood, P, Garcia-Marcos, L, Mallol, J, Marks, GB, Pearce, N, Strachan, D, Priftanji, A, Boukari, R, Taright, S, Gomez, M, Baghdasaryan, A, Burgess, S, Marks, GB, Mattes, J, Tai, A, Riedler, J, Shpakou, A, Weyler, J, Lawin, H, de Abruzzese, Aguirre J, Domuz, S, Brandao, H, Camargos, PAM, Fischer, GB, Menezes, AM, Porto Neto, AC, Rosario, N, Sole, D, Mustakov, TB, Birba, E, Ngahane, Mbatchou BH, Tse, SM, Standring, P, Aguirre, V, Calvo Gil, MA, Chen, Y-Z, Kan, X, Garcia, E, Niederbacher, J, Obel, Kabengele B, Soto-Quiros, ME, Banac, S, Yiallouros, P, Lochte, L, Barba, S, Bustos, C, El Falaki, M, Figueroa Colorado, M, Weihe, P, Lal, VA, Makela, M, Annesi-Maesano, I, Raherison, C, Annesi-Maesano, I, Gotua, M, von Mutius, E, Addo-Yobo, EO, Akpinar-Elci, M, Lai, CKW, Novak, Z, Kabra, SK, Ilangho, RP, Pherwani, A, Sharma, SK, Sukumaran, TU, Dalimunthe, W, Karimi, M, Masjedi, M-R, Manning, P, Shohat, T, Forastiere, F, La Grutta, S, Petronio, MG, Piffer, S, Kahwa, E, Odajima, H, Abu-Ekteish, F, Amukoye, EI, Esamai, FO, Hong, S-J, Neziri-Ahmetaj, L, Momen, JA, Akkhavong, K, Svabe, V, Vlaski, E, Mortimer, K, Daud, M, Montefort, S, Del Rio Navarro, BE, Jimenez Gonzalez, CA, Merida-Palacio, J, Paramo-Arroyo, RF, Munkhbayarlakh, S, Brunekreef, B, Annesi-Maesano, I, Asher, I, Currie, S, Douwes, J, Graham, D, Hancox, R, Moyes, C, Pattemore, P, Vis, K, Cordero, Rizo MZ, Ayuk, A, Falade, AG, Garba, Ilah B, Hammangabdo, A, Onyia, N, Pulu, M, Nystad, W, Al-Rawas, O, Yusuf, MO, Watson, BM, El Sharif, N, Cukier, G, Chiarella, P, Pagcatipunan, R, Breborowicz, A, Lis, G, Morais-Almeida, M, Annesi-Maesano, I, Deleanu, D, Kamaltynova, E, Kondiurina, EG, Esera-Tulifau, L, Al-Ghamdi, Memish, ZA, Nahhas, MA, Yousef, A, Toure, NO, Visnjevac, D, Zivkovic, Z, Deen, GF, Goh, DYT, Masekala, R, Zar, HJ, Carvajal-Uruena, I, Garcia-Marcos, L, Gonzalez Diaz, C, Korta Murua, J, Luna-Paredes, C, Morales-Suarez-Varela, M, Praena-Crespo, M, Kudagammana, ST, El Sony, A, Mohammad, Y, Guo, YL, Huang, J-L, Lao-Araya, M, Teeratakulpisarn, J, Vichyanond, P, Anderson, S, Tidjani, O, Iosefa, T, Aho, G, Dookeeram, D, Hamzaoui, A, Yorgancioglu, A, Ituaso-Conway, N, Worodria, W, Fedortsiv, O, Mahboub, B, Mansur, AH, Kumar, H, Valentin-Rostan, M, Harrison, G, Fiocchi, A, Le, LTT, Wa Somwe, S, Manangazira, P (2019-02-02). Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 16 (4). ScholarBank@NUS Repository. https://doi.org/10.3390/ijerph16040605 | Abstract: | Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013⁻2020 sets an 80% target for essential NCD medicines' availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013⁻2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses-41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system's capacity to address NCDs. | Source Title: | INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH | URI: | https://scholarbank.nus.edu.sg/handle/10635/228098 | ISSN: | 16617827 16604601 |
DOI: | 10.3390/ijerph16040605 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Essential Medicines at the National Level The Global Asthma Networks Essential Asthma Medicines Survey 2014. .pdf | Published version | 343.92 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.